Inventor · disambiguated record
Emanuel Petricoin
Also filed as: PETRICOIN EMANUEL · PETRICOIN EMANUEL F · PETRICOIN EMANUEL F III · PETRICOIN EMANUEL FRANK IV
23 granted patents·32 pending applications·315 citations·filing 2001–2019
95Inventor score
Files withGEORGE MASON INTELLECTUAL PROP9PERTHERA INC6UNIV GEORGE MASON5LIOTTA LANCE4LIOTTA LANCE A4
Top patents by PatentIndex Score
55 records- 0196US6925389B2Process for discriminating between biological states based on hidden patterns from biological dataUS HEALTH·Filed 2001·Granted Aug 2, 2005·152 cites·48 claims
- 0291USD826972SDisplay panel or portion thereof with a graphical user interfacePERTHERA INC·Filed 2017·Granted Aug 28, 2018·62 cites·1 claims
- 0388US8168568B1Combinatorial therapy for protein signaling diseasesMEHTA ARPITA I·Filed 2009·Granted May 1, 2012·19 cites·90 claims
- 0486US7333896B2Quality assurance/quality control for high throughput bioassay processCORRELOGIC SYSTEMS INC·Filed 2003·Granted Feb 19, 2008·12 cites·27 claims
- 0582US8628931B2mTOR pathway theranosticLIOTTA LANCE A·Filed 2006·Granted Jan 14, 2014·7 cites·28 claims
- 0681US9383299B2Method for harvesting nanoparticles and sequestering biomarkersKUNKEL ALESSANDRA LUCHINI·Filed 2013·Granted Jul 5, 2016·7 cites·1 claims
- 0781US8834873B2Method for detecting and controlling cancerPETRICOIN III EMANUEL F·Filed 2007·Granted Sep 16, 2014·9 cites·31 claims
- 0877US8382987B2Method for harvesting nanoparticles and sequestering biomarkersLUCHINI ALESSANDRA·Filed 2008·Granted Feb 26, 2013·9 cites·3 claims
- 0975US7935518B2Smart hydrogel particles for biomarker harvestingLUCHINI ALESSANDRA·Filed 2008·Granted May 3, 2011·7 cites·4 claims
- 1074US9086414B2Phosphorylated C-ErbB2 as a superior predictive theranostic marker for the diagnosis and treatment of cancerPETRICOIN III EMANUEL F·Filed 2009·Granted Jul 21, 2015·1 cites·49 claims
- 1173USD827664SDisplay panel or portion thereof with a graphical user interfacePERTHERA INC·Filed 2017·Granted Sep 4, 2018·17 cites·1 claims
- 1271US2008103063A1Quality Assurance/Quality Control for High Throughput Bioassay ProcessHITT BEN A·Filed 2008·Application pending·0 cites
- 1364USD851665SDisplay panel or portion thereof with a graphical user interfacePERTHERA INC·Filed 2017·Granted Jun 18, 2019·11 cites·1 claims
- 1459US2008243394A1System, method and computer program product for manipulating theranostic assaysTHERANOSTICS LLC·Filed 2008·Application pending·0 cites
- 1559US2010003247A1Assay for metastatic colorectal cancerGEORGE MASON INTELLECTUAL PROP·Filed 2007·Application pending·0 cites
- 1658US9005996B2Method of isolating analytes from a sampleLIOTTA LANCE·Filed 2006·Granted Apr 14, 2015·1 cites·16 claims
- 1758US2011046039A1Post-exposure prophylaxis and treatment of infectionsGEORGE MASON INTELLECTUAL PROP·Filed 2008·Application pending·0 cites
- 1858US2008069774A1Proteomic antisense molecular shield and targetingLIOTTA LANCE·Filed 2007·Application pending·0 cites
- 1958US2015118246A1Method for detecting and controlling cancerGEORGE MASON RES FOUNDATION INC·Filed 2014·Application pending·0 cites
- 2057US2005260671A1Process for discriminating between biological states based on hidden patterns from biological dataHITT BEN A·Filed 2005·Application pending·0 cites
- 2157US2011200597A1Signal pathway alterations and drug target elevations in primary metachronous metastatic colorectal cancer compared to non-metastatic diseaseGEORGE MASON INTELLECTUAL PROP·Filed 2009·Application pending·0 cites
- 2257US2005042636A1Compositions and methods for detecting abnormal cell proliferationFiled 2004·Application pending·0 cites
- 2355US11475995B2Integration of multi-omic data into a single scoring model for input into a treatment recommendation rankingPERTHERA INC·Filed 2019·Granted Oct 18, 2022·0 cites·46 claims
- 2454US7794952B2Biomarker isolation and use thereof to characterize physiological stateUNIV GEORGE MASON·Filed 2006·Granted Sep 14, 2010·0 cites·13 claims
- 2553US11574718B2Outcome driven persona-typing for precision oncologyPERTHERA INC·Filed 2019·Granted Feb 7, 2023·0 cites·17 claims
- 2652US9012240B2Hydrogel nanoparticle based immunoassayLIOTTA LANCE A·Filed 2009·Granted Apr 21, 2015·0 cites·1 claims
- 2751US11408896B2Methods for discovering protein-protein interactionsUNIV GEORGE MASON·Filed 2019·Granted Aug 9, 2022·0 cites·20 claims
- 2851US8497137B2Smart hydrogel particles for biomarker harvestingLUCHINI ALESSANDRA·Filed 2008·Granted Jul 30, 2013·1 cites·2 claims
- 2951US2011207627A1Ex vivo therapeutics screening of living bone marrow cells for multiple myelomaUNIV GEORGE MASON·Filed 2009·Application pending·0 cites
- 3051US2020128864A1Edible, shelf-stable, water-soluble oil-in-syrup emulsions of microparticle-encapsulated cannabinoids and uses thereofPETRICOIN EMANUEL FRANK IV·Filed 2019·Application pending·0 cites
- 3151US2016320401A1Method and apparatus for signal transduction pathway profilingIMMUNOMATRIX INC·Filed 2016·Application pending·0 cites
- 3250US8835360B1Combinatorial therapy for protein signaling diseasesMEHTA ARPITA I·Filed 2012·Granted Sep 16, 2014·0 cites·60 claims
- 3350US2010203549A1Calibrated rpma assayGEORGE MASON INTELLECTUAL PROP·Filed 2008·Application pending·0 cites
- 3449US2010105087A1Biomarkers for breast cancerGEORGE MASON INTELLECTUAL PROP·Filed 2007·Application pending·0 cites
- 3549US2010143949A1Biomarkers for colorectal cancerGEORGE MASON INTELLECTUAL PROP·Filed 2007·Application pending·0 cites
- 3649US2005005311A1High throughput screening for cancer genesFiled 2004·Application pending·0 cites
- 3748US2009275546A1Diagnostic tests and personalized treatment regimes for cancer stem cellsIST SUPERIORE SANITA·Filed 2009·Application pending·0 cites
- 3848US2010317740A1Method for Predicting Response to TamoxifenGEORGE MASON INTELLECTUAL PROP·Filed 2008·Application pending·0 cites
- 3947US2011318336A1Identification and Treatment of Aggressive Lung Cancer TumorsPETRICOIN III EMANUEL·Filed 2011·Application pending·0 cites
- 4046US2008255243A1Stat3 as a theranostic indicatorPETRICOIN EMANUEL F·Filed 2008·Application pending·0 cites
- 4146US2010159486A1Biomarkers for neurological conditionsGEORGE MASON INTELLECTUAL PROP·Filed 2007·Application pending·0 cites
- 4246US2007224644A1Ocular fluid markersLIOTTA LANCE A·Filed 2007·Application pending·0 cites
- 4345US2013344062A1Identification and Treatment of Aggressive Lung Cancer TumorsPETRICOIN III EMANUEL·Filed 2013·Application pending·0 cites
- 4444US10823738B2Methods for breast cancer treatmentUNIV GEORGE MASON·Filed 2016·Granted Nov 3, 2020·0 cites·14 claims
- 4544US2010298157A1Phosphoproteomic evaluation of diabetes and obesityGEORGE MASON INTELLECTUAL PROP·Filed 2008·Application pending·0 cites
- 4644US2011137627A1Method and system for homologous control of networksNAPOLETANI DOMENICO·Filed 2010·Application pending·0 cites
- 4742US9335328B2Method and apparatus for signal transduction pathway profilingLIOTTA LANCE A·Filed 2001·Granted May 10, 2016·0 cites·8 claims
- 4841US2014030254A1Signal pathway alterations and drug target elevations in primary metachronous metastatic colorectal cancer compared to non-metastatic diseasePETRICOIN III EMANUEL F·Filed 2013·Application pending·0 cites
- 4940US2012321615A1Assay for Metastatic Colorectal CancerPETRICOIN III EMANUEL·Filed 2012·Application pending·0 cites
- 5039US10690672B2Methods for breast cancer treatmentUNIV GEORGE MASON·Filed 2015·Granted Jun 23, 2020·0 cites·9 claims
Showing the top 50 of 55 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Emanuel Petricoin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →